1-5 of 5
Leonie K. Ashman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4364: Posttranscriptional regulation of tetraspanins CD151 & CD9 in breast & prostate cancers

Danielle R. Bond, Crystal Passfield, Murray Cairns, Leonie K. Ashman, Judith Weidenhofer
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4364.
https://doi.org/10.1158/1538-7445.AM2014-4364
Published: 01 October 2014
View article titled, Abstract 4364: Posttranscriptional regulation of tetraspanins CD151 & CD9 in breast & prostate cancers
Journal Articles

Abstract 5283: Regulation of tetraspanins CD151 and CD9 by micro-RNA in breast and prostate cancers.

Danielle R. Bond, Murray Cairns, Leonie K. Ashman, Judith Weidenhofer
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5283.
https://doi.org/10.1158/1538-7445.AM2013-5283
Published: 15 April 2013
View article titled, Abstract 5283: Regulation of tetraspanins CD151 and CD9 by micro-RNA in breast and prostate cancers.
Journal Articles

Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers

Kathryn G. Roberts, Amanda M. Smith, Fiona McDougall, Helen Carpenter, Martin Horan, Paolo Neviani, Jason A. Powell, Daniel Thomas, Mark A. Guthridge, Danilo Perrotti, Alistair T.R. Sim, Leonie K. Ashman, Nicole M. Verrills
Journal: Cancer Research
Cancer Res (2010) 70 (13): 5438–5447.
https://doi.org/10.1158/0008-5472.CAN-09-2544
Published: 30 June 2010
View article titled, Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers
Open the PDF for Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers in another window
Includes: Supplementary data
Journal Articles

An In vivo Tumor Model Exploiting Metabolic Response as a Biomarker for Targeted Drug Development

Carleen Cullinane, Donna S. Dorow, Maya Kansara, Nelly Conus, David Binns, Rodney J. Hicks, Leonie K. Ashman, Grant A. McArthur, David M. Thomas
Journal: Cancer Research
Cancer Res (2005) 65 (21): 9633–9636.
https://doi.org/10.1158/0008-5472.CAN-05-2285
Published: 01 November 2005
View article titled, An <em>In vivo</em> Tumor Model Exploiting Metabolic Response as a Biomarker for Targeted Drug Development
Open the PDF for An <em>In vivo</em> Tumor Model Exploiting Metabolic Response as a Biomarker for Targeted Drug Development in another window
Journal Articles

Protective Effect of Oral Salmonella enteritidis 11RX Infection against Colon Tumor Induction by 1,2-Dimethylhydrazine in Mice

Leonie K. Ashman, Martin G. Cook, Ieva Kotlarski
Journal: Cancer Research
Cancer Res (1979) 39 (7_Part_1): 2768–2771.
Published: 01 July 1979
View article titled, Protective Effect of Oral <em>Salmonella enteritidis</em> 11RX Infection against Colon Tumor Induction by 1,2-Dimethylhydrazine in Mice
Open the PDF for Protective Effect of Oral <em>Salmonella enteritidis</em> 11RX Infection against Colon Tumor Induction by 1,2-Dimethylhydrazine in Mice in another window